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Abstract
Objective—Epilepsy is a chronic neurological condition that significantly increases risk of injury 
and premature death. Rates of mental illness are also disproportionately high in those with 
epilepsy, which can be attributed in part to the stress and stigma associated with epilepsy. 
Psychiatric conditions generally complicate the management of epilepsy, and understanding how 
psychiatric comorbidity affects use of crisis-based health resources could inform care approaches 
that help improve epilepsy care. To better understand effects of psychiatric comorbidity on 
epilepsy burden, we conducted a 5-year retrospective analysis of data from a large safety-net 
healthcare network and compared the occurrence of negative health events (NHEs), defined as 
emergency department (ED) visits and hospitalizations, among individuals with epilepsy and 
mental illness (E–MI) vs. those with epilepsy alone (E).
Methods—Electronic health record (EHR) data from a large Midwestern U.S. safety-net 
healthcare system were queried to identify a study population of adults ≥18 years with a diagnosis 
of epilepsy, with or without mental illness. We assessed demographic and clinical characteristics 
for each of the 5 years and compared NHEs between subgroups with E–MI vs. E. An additional 
analysis focused on those individuals who remained in the healthcare system over the entire 5-year 
study time frame (January, 2010 to December, 2014). Annual and cumulative NHE counts and 
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hospital length of stay for individuals with E–MI and E were assessed, as were hospital discharge 
diagnoses.
Results—The number (approximately 2000) and demographic characteristics of individuals with 
epilepsy who received care each year of the study period was relatively consistent. In 2014, mean 
age of individuals with epilepsy was 48 (range: 18–95), 48.2% were women, 51.5% were White, 
37.9% were African-American, and 8.6% were Hispanic. In 2014, there were 1616 (78.6%) 
individuals in the subgroup with E and 439 (21.4%) in the subgroup with E–MI. Most clinical and 
demographic variables between the subgroups with E–MI and E were similar, except that 
individuals with E–MI were less likely to be employed or commercially insured. Overall, NHEs 
were common, with over 1/4 (27.5%) of all individuals with epilepsy having an ED visit during 
the year, 13.7% having hospitalization, and 34.2% having either an ED visit or hospitalization. 
Individuals with E–MI had significantly more NHEs compared to individuals with epilepsy only, 
as evidenced by higher rates of any NHE (p < .001), ED visits (p < .001), and hospitalizations (p 
< .001). The cumulative differential in ED and hospital use between subgroups with E–MI and E 
was substantial over a 5-year time period. While most NHEs were directly related to seizures for 
the overall group, substance-use complications appeared as a top reason for hospitalization only in 
the group with E–MI.
Conclusions—Individuals with E–MI made up just over 20% of all people with epilepsy in a 
safety-net system and had higher rates of NHEs than those without mental illness. Better and 
earlier identification of individuals with E–MI, assistance with self-management including helping 
individuals to optimize ambulatory care settings as opposed to the ED, and treatment for substance 
use disorders could eventually reduce NHEs in this vulnerable subgroup of individuals with 
epilepsy.
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1. Introduction
Epilepsy is a chronic neurological condition with a lifetime prevalence of 1.8% [1]. Epilepsy 
significantly increases risk of injury and premature death [2,3], and standardized mortality 
ratios as high as 2.4 to 5.6 have been reported for epilepsy-related accidental deaths, while 
approximately 30% of people with epilepsy experience seizure-related injury. In addition to 
injury and death, recurrent seizures are often associated with psychological comorbidity 
[4,5]. Rates of mental illness (MI), such as schizophrenia, bipolar disorder, and recurrent or 
severe depression, are disproportionately high in those with epilepsy. It is estimated that 20–
30% of people with epilepsy have comorbid mental illnesses [6–12]. Depression is 
particularly common [13], and individuals with epilepsy are 4 times more likely to be 
hospitalized with depression than those without epilepsy [14]. Rates of psychotic illness in 
epilepsy are 6–12 times higher than in the general population, with a prevalence of 7–8% 
[15]. Additionally, rates of bipolar disorder in people with epilepsy may be as high as 12% 
[16,17].
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A recent survey [18] noted that almost half of people with epilepsy reported having a seizure 
in the previous 3 months. Risk factors for ongoing seizures and poorly controlled epilepsy 
include comorbidities, as well as medication non-adherence and poor social support. 
Individuals of lower socioeconomic status may be particularly likely to have negative health 
events (NHEs), such as frequent or poorly controlled seizures and hospitalizations [19]. 
Some reports note that having a psychiatric condition may lower seizure threshold or 
increase risk of treatment-resistant epilepsy [20,21]. Heavy stigma burden, lack of support, 
social disadvantages (e.g., unemployment), and isolation may result in poorer outcomes for 
persons with epilepsy and comorbid mental illnesses. The risk for suicide among people 
with epilepsy is 5 times the rate of the general population, possibly because of under-treated 
mental illness, suboptimal health self-management, or the synergistic negative effects of E–
MI comorbidity [22–24].
An Institute of Medicine (IOM) report on epilepsy noted that addressing comorbidity 
burden, particularly with respect to mental disorder, is a priority area [25]. Since 2009, the 
Centers for Disease Control and Prevention (CDC) Prevention Research Centers' Managing 
Epilepsy Well (MEW) Network has focused its efforts on addressing mental health issues in 
epilepsy [26,27]. Supplementing this effort, in order to better understand the association of 
psychiatric conditions with health care utilization among persons with epilepsy, we 
conducted a 5-year retrospective analysis of data from a large safety-net healthcare network 
and compared the occurrence of NHEs, defined as emergency department (ED) visits and 
hospitalizations, among individuals with epilepsy and MI and those with epilepsy alone (E).
2. Methods
2.1. Overview
This 5-year retrospective medical record review used data from a single healthcare system's 
inpatient, outpatient, and emergency department (ED) settings to compare the occurrence of 
negative health events (NHEs) in people with epilepsy and comorbid mental illness vs. 
people with epilepsy not diagnosed with mental illness. Because the healthcare system is a 
safety-net system, it provides services to individuals regardless of their ability to pay. 
Safety-net care systems generally serve higher proportions of minorities and individuals of 
lower socioeconomic status than most commercially insured networks. In addition to NHEs, 
the analysis compared demographic and clinical characteristics of E–MI vs. E. The study 
was approved by the local Institutional Review Board (IRB).
2.2. Study population and time frame
Electronic health record (EHR) data from a large Midwestern U.S. safety-net healthcare 
system were queried to identify a study population of adults, aged 18 and above, with a 
diagnosis of epilepsy and with at least 1 visit to the care system's primary care or neurology 
outpatient or inpatient settings within the past 5 years. The EHR system used was Epic, one 
of the most widely used systems nationally, accounting for 20.3% of the EHR market share 
[28]. Epilepsy cases were identified based upon an epilepsy diagnosis (ICD-9-CM codes 
345.1–345.91) on the EHR problem list. Mental disorder cases were identified by having a 
mental disorder on the EHR problem list (ICD-9-CM codes 295–296.89) or by being 
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prescribed a medication that is generally only used to treat a chronic bipolar or psychotic 
disorder (antipsychotic drugs or lithium). The study time frame of observation was January 
2010 to December 2014.
2.3. Demographic and clinical variables
We assessed age (in years), gender, race, insurance status, employment status, and number 
of neurology and primary care visits. Patient addresses were geo-coded to obtain the census 
block group, which was then used to retrieve the median neighborhood income and high 
school graduation rate. Income and education results were altered by a random amount to 
obscure the exact residence location. Once the census data were coded and complete, the 
dataset was entirely de-identified, and only de-identified data were used for analysis 
purposes.
2.4. Negative health events (NHEs) and health resource use
Negative health event occurrence was defined as emergency department (ED) visits and/or 
hospitalization. If an individual was admitted to the hospital from the ED, only the 
hospitalization was counted as an NHE. For individuals who had hospitalizations, hospital 
discharge diagnosis was assessed.
2.5. Data analysis
Demographics and clinical characteristics of the sample in each of the 5 years of the study 
time frame were summarized by means and standard deviations for continuous variables and 
by frequency and proportions for categorical variables. As some individuals dropped in and 
out of treatment, or did not stay in the care system consistently, each year was treated as a 
discrete sample. The subgroups of individuals with E–MI and E were described separately. 
To compare the subgroups with E–MI and E, two-sample Mann–Whitney U tests were used 
for count data and Fisher's exact test for binary outcomes.
An additional analysis was conducted, focusing on those individuals who remained in the 
healthcare system over the entire 5-year study time frame (from January 2010 to December 
2014). The annual and cumulative NHE counts for individuals with E–MI and E were 
assessed, as was hospital discharge diagnosis. For NHE counts as the dependent variable 
(each year, over the 5 years), a negative binomial count regression model was fitted. 
Subject-level random effects were included to account for within-subject correlation. 
Covariates that were considered were age, race, gender, employment status, and insurance 
status, as well as an indicator variable for E–MI status. The latter variables were based on 
2014 data. Primary focus was the effect of E–MI status on NHE counts. For the employment 
variable: subjects were considered as employed if their status in the database was listed as 
full time, part time, or self-employed; they were considered as not employed if their status 
was either not employed, retired, full- or part-time student. For the race variable, declined 
and unavailable were considered in one group as unknown. SPSS v. 22 (IBM Corp. released 
2013. IBM Statistical Package for the Social Sciences Statistics for Windows, version 22.0. 
Armonk, NY: IBM Corp.) was used for data analysis.
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3. Results
3.1. Overall sample description
As noted in Fig. 1, the number of unique individuals with epilepsy who received care each 
year of the 5-year study period was very consistent at approximately 2000 persons annually, 
ranging from 1976 (in 2011) to 2055 (in 2014). Fig. 1 also illustrates the proportion of 
individuals with MI vs. those who did not have MI in each year of the study period. On 
average, individuals with MI comprised just over 20% of all patients with epilepsy. 
Demographic and clinical variables also remained fairly consistent across the 5-year period; 
Table 1 illustrates these variables in the last year of the study time frame (2014). In the 2014 
sample, mean age of all individuals with epilepsy was 48 (SD: 14.6, range: 18–95), 48.2% 
were women, 51.5% were White, 37.9% were African-American, and 8.6% were Hispanic. 
The majority of individuals were insured by national or state-funded health plans (Medicare 
and Medicaid). The biggest change in demographic/clinical variables over the 5-year period 
was in insurance status. Rates of being uninsured dropped substantially from 2010 to 2014, 
with 19.1% in 2010, 19.1% in 2011, 17.1% in 2012, 5.6% in 2013, and 4.2% in 2014, while 
Medicaid insurance rates increased. Only 20.4% of the entire sample was employed, and 
most lived in limited financial circumstances, with a mean neighborhood household income 
of U.S. $38,400/year.
In the 2014 sample, there were 1616/2055 (78.6%) individuals in the subgroup with E and 
439/2055 (21.4%) in the subgroup with E–MI. Most clinical and demographic variables 
between the subgroups with E–MI and E were similar, except that individuals with E–MI 
appeared less likely to be employed (p = .001) and less likely to have commercial health 
insurance (p = .007), as assessed through chi-squared tests.
3.2. NHEs and resource use
As noted in Table 1, NHEs were common in this sample of individuals with epilepsy. Over 
1/4 (27.5%) of all individuals with epilepsy had an ED visit during the year, 13.7% were 
hospitalized, and 34.2% had either an ED visit or hospitalization. Mean number of NHEs 
overall was 0.9 (SD: 2.4), with a range of 0–31 NHEs. Particularly striking is the fact that 
half (50%) of individuals with E–MI had at least 1 NHE over the course of a year. 
Individuals with E–MI had significantly more NHEs compared to individuals with epilepsy 
only, as evidenced by higher rates of any NHE (p < .001), ED visits (p < .001), and 
hospitalizations (p < .001). We consider multivariate analysis of NHE counts below.
There were 981 individuals with epilepsy [including 198 (20.2%) with E–MI] who remained 
in the health system for the entire 5-year duration of the study observation period. Table 2 
illustrates annual NHE occurrence in this sample of 981 individuals during each of the 5 
study years, categorized by NHEs overall, ED visits, and hospitalizations.
For the 981 individuals who utilized the healthcare system every year over the 5-year period, 
we fit a mixed model negative binomial regression of the NHE count data. In this model 
there was a highly significant difference between the groups with E–MI and E, with the 
group with E–MI having higher expected NHE counts (p < .001). Significant covariates 
were race (p < .001), age (p = .003), employment status (p < .001), and insurance status (p 
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< .001). Hispanics had significantly higher expected NHE counts relative to Whites, while 
African-Americans did not. Younger subjects and those with Medicaid also had higher 
expected NHE counts. For these same individuals who used the healthcare system over the 
5-year period, Figs. 2 and 3 illustrate cumulative differences in groups with E–MI vs. E 
expressed as rates of ED visits and rates of hospitalizations per 100 individuals.
Table 3 illustrates the top reasons for hospital discharge among the 981 individuals with 
epilepsy who used the safety-net healthcare system over a 5-year period (number of 
cumulative admissions and % of all hospitalizations for each subgroup: all individuals with 
epilepsy, subgroup with E–MI, and subgroup with E). Negative health events in this sample 
were mostly related to having epilepsy or seizures. In both groups with E and E–MI, 
epilepsy or seizures were the top hospitalization discharge diagnosis. But a major difference 
in reasons for hospitalization in groups with E–MI vs. E were hospitalizations for alcohol or 
other drug intoxication/poisoning, which were in the top 5 causes of hospitalization for the 
group with E–MI but did not appear in the top 5 list of hospitalizations for those people with 
epilepsy who did not have MI.
4. Discussion
The results of this 5-year retrospective EHR-facilitated analysis of individuals with epilepsy 
cared for in a large safety-net healthcare system in the U.S. suggested that, while annual 
overall rates of using the ED or hospital for crisis care were relatively high at almost 38%, 
individuals with psychiatric comorbidity had significantly more NHEs compared to 
individuals with epilepsy that was not complicated by mental illness. Our findings are 
consistent with other reports noting that psychiatric comorbidity substantially increases 
healthcare use in people with epilepsy [29,30].
Wilner and colleagues [29] recently reported that, in a study involving 6621 individuals with 
epilepsy from eight commercial health plans, 50% of men and 43% of women with epilepsy 
had 1 or more comorbidities. Psychiatric diagnoses were the top comorbidity for both 
women and men in this commercially-insured sample. Among women, top comorbidities 
were psychiatric diagnosis (16%), hypertension (12%), asthma (11%), hyperlipidemia 
(11%), and headache (7%). Among men, top comorbidities were psychiatric diagnosis 
(15%), hyperlipidemia (12%), hypertension (12%), asthma (8%), and diabetes (5%). In the 
study by Wilner, having one comorbidity approximately tripled the health-care costs 
compared to individuals without comorbidity. Individuals with epilepsy in our safety-net 
care system sample had higher rates of psychiatric diagnoses than those in the report by 
Wilner [29], which may be reflective of differences in commercially insured vs. publicly 
insured groups. An additional important difference in our sample compared to the report by 
Wilner and colleagues [29] is the fact that our safety-net health system sample focused on 
those with more severe mental illness, such as chronic psychosis or bipolar disorder, vs. a 
broader (and potentially less disabling) group of mental conditions, such as anxiety or mild 
depression.
In our sample, approximately 1 in 5 individuals with epilepsy had psychiatric comorbidity, 
and individuals with E–MI had more NHEs overall, including more ED visits and more 
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hospitalizations. This difference was sustained over a 5-year period, and the group with E–
MI consistently had greater service use, including more ED visits and more hospitalizations. 
Over time, individuals with E–MI appear to have more health-related complications and use 
a disproportionate amount of health care services than people with epilepsy and no 
psychiatric comorbidity.
The majority of individuals with epilepsy in our sample received healthcare that was 
publicly funded (Medicare or Medicaid). Consistent with the general population served by 
this safety-net system, nearly 80% of all patients with epilepsy in this sample were not 
employed, and most lived in poor neighborhoods with relatively low annual household 
income levels. The number of individuals who were uninsured decreased over the 5-year 
study time period from around 20% to around 5%, which is consistent with what occurred in 
this safety-net system generally and was mainly driven by policy changes supported by the 
Affordable Care Act, including a federally approved Medicaid Waiver initiative in the health 
system in 2013 and state Medicaid expansion in 2014. In our setting, Hispanic patients with 
epilepsy [31] experienced a disproportionate amount of NHEs. It is possible that at least 
some of the ethnic disparity could have been due to care access based upon insurance 
coverage, and perhaps NHE occurrence will change in the future with the newly expanded 
healthcare coverage.
Negative health events in this sample were mostly related to having epilepsy or seizures. But 
in the group with E–MI, some health-related problems appeared to be related to the highly 
destructive effects of psychiatric illness, including poor epilepsy management and unhealthy 
behaviors, such as use of drugs or alcohol. It is known that the use of both legal (alcohol) 
and illicit substances (cocaine, etc.) may reduce effectiveness of antiepileptic drugs or may 
be associated with a lifestyle that interferes with appropriate management of epilepsy [32]. 
Alcohol, cannabis, and cocaine have negative effects on cognitive functioning, such as 
decreased verbal fluency and working memory, as well as deleterious effects on decision-
making [33].
There are a number of clinical implications inherent in our study findings. First, recognition 
of comorbid psychiatric illness appears to be a crucial factor in being able to reduce the use 
of crisis care by individuals with epilepsy. Routine screening for psychiatric illness and 
possibly tapping into the capacity of an EHR to help identify individuals with comorbidity 
may be reasonable methods to augment ongoing clinical assessment for depression, bipolar 
mania, or other psychiatric symptoms that are typical in serious mental illness. Second, once 
psychiatric comorbidity is identified, individuals with E–MI may benefit from targeted self-
management approaches that address depression, stress, and other common emotional 
problems in people with epilepsy [26,27,34–36]. The MEW Network has been a leader in 
developing care approaches that specifically address depression and other mental illnesses in 
people with epilepsy, who may be doubly-stigmatized because of having two health 
conditions that can be associated with social isolation and exclusion [27]. Aspects of self-
management that may be particularly important in people with epilepsy and comorbid 
psychiatric symptoms include adherence to both antiepileptic drugs and medications for 
treatment of mental disorders and communication with providers to preemptively manage 
side effects and adverse events in ambulatory settings as opposed to ED care [36]. As 
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evidenced by our findings, care in those with E–MI needs to include attention to the use of 
substances that may further complicate the course of epilepsy, as well as addressing the 
social determinants of health, such as unemployment, insurance, and disability status that 
can contribute to or exacerbate the negative effects of mental disorders.
Our study has a number of limitations that may affect interpretation or generalizability of 
findings, such as a relatively limited sample size and a single health system setting. A 
retrospective medical record study such as ours may have a number of liabilities such as the 
possibility of incomplete records, misdiagnosis, miscoding, and other data entry problems. It 
is possible that some E–MI was undetected, as chart diagnoses may underreport stigmatizing 
conditions such as mental illnesses. Our reliance on categorical EHR data (e.g., 
demographic variables and billing codes) did not allow us to identify details that might have 
been included in the narrative clinical record, such as whether epilepsy was primary or 
secondary to comorbidities or whether seizures were possibly nonepileptic in nature. 
Additionally, some patients may have been treated for NHEs in different care settings, and 
the NHEs were, thus, not captured in this database. This would be particularly likely for 
NHEs where it might be expected that emergency medical services would take patients to 
the closest ED, regardless of whether it was in the patients' usual care setting or not. Finally, 
the study methodology did not permit a finer-grained analysis of the wide variety of 
negative health outcomes and complications that can happen to individuals with epilepsy, 
such as seizures that do not result in hospitalization or ED visit and suicide or suicide 
attempts that do not come to the attention of medical professionals. While these are all 
potentially important limitations, the strengths of this analysis include the 5-year time frame 
that facilitated observation of the consistency of findings and the fact that the safety-net 
system covers a relatively wide geographic setting with multiple clinical sites, increasing the 
likelihood that patients would use the health system for most, if not all, of their healthcare 
needs. An additional strength of the analysis is that it includes a substantial portion of 
minorities with epilepsy, a feature not found in some other samples with epilepsy [37].
5. Conclusion
In conclusion, among individuals with epilepsy who use a safety-net health system, 
approximately 1/3 of individuals will have an NHE over a 1-year time period. Individuals 
with E–MI have even higher rates of NHEs than those who do not have psychiatric 
comorbidity, and the cumulative differential in ED and hospital use is substantial over a 5-
year time period. Optimizing screening and appropriate treatment for mental disorder may 
help in identifying individuals with E–MI who could benefit from epilepsy self-
management. Care approaches should include a focus on using ambulatory rather than ED 
settings for healthcare decision-making and management of substance use disorders. 
Specialized care approaches that address the unique challenges and problems of people with 
E–MI might be able to eventually reduce NHEs in this vulnerable subgroup of individuals 
with epilepsy.
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Fig. 1. 
Patients included in study by year.
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Fig. 2. 
Cumulative differences in ED visits.
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Fig. 3. 
Cumulative differences in hospitalizations.
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Table 3
Most common hospital discharge diagnoses for individuals with epilepsy who remained in a safety-net 
healthcare system over a 5-year time period.
All individuals with epilepsy Individuals with epilepsy and no MI Individuals with E–MI
Sample size 981 783 198
Total discharges 1010 707 303
1 or more hospitalizations, N 
(%) 381 277 (35.4) 104 (52.5)
Top 5 discharge diagnostic 
categories, N (%)a Epilepsy – 178 (17.6) Epilepsy – 115 (16.3) Epilepsy – 63 (20.8)
Septicemia – 32 (3.2) Septicemia – 30 (4.2) Alcohol-related disorder – 13 (4.3)
Pneumonia – 28 (2.8) Pneumonia – 23 (3.3) Skin infection – 11 (3.6)
Diabetes – 24 (2.4) Dysrhythmia – 21 (3.0) Poisoning by meds or drugs – 10 (3.3)
Dysrhythmia – 23 (2.3) CHF – 18 (2.6) COPD – 9 (3.0)
MI: Mental illness.
E–MI: Epilepsy + comorbid mental illness.
COPD: Chronic obstructive pulmonary disease.
CHF: Congestive heart failure.
a
Discharge diagnoses grouped using Clinical Classifications Software (CCS) for ICD-9-CM as suggested by Cowen ME, Dusseau DJ, Toth BG, et 
al. Casemix adjustment of managed care claims data using the clinical classifications for health policy research method. Medical Care, 1998, 
36:1108–1113.
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